410 results on '"Ademi Z"'
Search Results
2. Is Remoteness Associated With Receipt of and Adherence to Secondary Prevention Medications post STEMI? A Victorian Linked Cohort Study
3. Bempedoic Acid and Ezetimibe for the Primary Prevention of Coronary Heart disease in the Statin-intolerant Patient: A Cost-effectiveness Analysis From the Australian Healthcare Perspective
4. Lipid Lowering Strategies for Primary Prevention of Coronary Heart Disease in Australia: A Cost-effectiveness Analysis Using Mendelian Randomisation
5. RWD146 Economic Burden Associated With Streptococcus Suis Infection Treatment in Northern Thailand: A Hospital-Based Observational Study
6. EPH51 The Health and Economic Burden of Bushfires in Australia Between 2021 and 2030: A Modelling Study
7. EPH81 The Productivity Burden of Sleep Apnoea in Australia Over a Lifetime: A Modelling Study
8. EE262 An Economic Evaluation and Return on Investment of the Community Benefit of the Australian Pregnancy Register of Anti-Seizure Medications
9. HTA168 Data Maturity and Treatment Positioning to Support Reimbursement: The Case for Siltuximab (SYLVANT®) in Australia
10. EE217 Population Genomic Screening for Tier 1 Genomic Applications: A Cost-Effectiveness Analysis
11. Dutch Nationwide Implementation Program for familial hypercholesterolemia case finding in children: a cost-effectiveness and return on investment analysis
12. Enhancing the potential for increased primary care role in familial hypercholesterolaemia detection and management: Cost-effectiveness and return on investment
13. EE217 Lost Therapeutic Benefit of Delayed LDL-C Control and Cost-Effectiveness Analysis of Lipid-Lowering Intensification
14. EPH79 Projections of Future Health and Economic Burden of Cardiovascular Disease Among Patients with Type 2 Diabetes Mellitus in Australia. Estimates up to 2030
15. EE352 Projecting the Incidence and Costs of Major Cardiorenal Complications of Type 2 Diabetes with Widespread GLP-1 RA and SGLT2I Use
16. EE157 National Implementation of a Lifestyle Intervention to Reduce Gestational Weight Gain Provides Large Returns on Investment: A Budget Impact Analysis for Australia
17. EPH70 Equity in Economic Evaluations of Early Childhood Development Interventions in Low-and Middle-Income Countries: Scoping Review
18. Economic evaluation of compression therapy in venous leg ulcer randomised controlled trials: A systematic review
19. P8 New Onset Cardiovascular Disease in Australia by Socioeconomic Groups: A Modelling Study
20. POSC63 Cost-Effectiveness of Non-Statin Lipid-Modifying Agents for Primary and Secondary Prevention of Cardiovascular Disease Among Patients with Type 2 Diabetes Mellitus: A Systematic Review
21. POSB167 Cost-Effectiveness of Tobacco Control Strategies in Indonesia
22. Population Genomic Screening of Young Adults for Familial Hypercholesterolaemia: A Cost-Effectiveness Analysis
23. POSA388 Attainment of Low-Density Lipoprotein Cholesterol Targets in Patients Treated with Combination Therapy in Australia: A Retrospective Cohort Study of a Primary Care Database
24. POSC32 Attainment of Low-Density Lipoprotein Cholesterol Targets in Statin Treated Patients: Real-World Evidence from Australian Primary Care
25. P4 Switching, Persistence and Adherence to Statin Therapy: A Retrospective Cohort Study Using the Australian National Pharmacy Data
26. Cost burden and cost-effective analysis of the nationwide implementation of the Quality in Acute Stroke Care protocol in Australia
27. Population genomic screening of all young adults in Australia to detect familial hypercholesterolemia: a cost-effectiveness analysis
28. Treatment specific utility-weightings are needed for cost–utility analysis in metastatic melanoma: reply from the authors
29. A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss setting
30. Evaluating the Cost-Effectiveness of Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease in Australia.
31. Study of CaDreb2c and CaDreb2h Gene Sequences and Expression in Chickpea (Cicer arietinum L.) Cultivars Growing in Northern Kazakhstan under Drought
32. PNS199 A Systematic Search and Review of Methodologies for the Economic Evaluation of HOME-Visiting Interventions
33. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: many happy returns on investment?
34. Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective
35. The impact of coronary heart disease on productivity in Australia over ten years
36. PCV13 Health Economic Evaluation of Screening and Treating Children with Familial Hypercholesterolemia EARLY in Life: Many Happy Returns on Investment?
37. PNS16 Health and Economic Burden of Smoking in Indonesia
38. PMH2 The IMPACT of Major Depression on Productivity in South Korea
39. PND15 The Health and Productivity Burden of Migraines in Australia
40. PIN65 ESTIMATING THE LIFETIME ECONOMIC BURDEN OF STREPTOCOCCUS SUIS AND ITS PRODUCTIVITY IMPACT IN THAILAND
41. 176 The Cost-Effectiveness of Dapagliflozin for Chronic Heart Failure in Australia
42. 725 Cost Effectiveness of Bempedoic Acid for Those at High Risk Cardiovascular Disease
43. 468 Cost-Effectiveness Analysis of Inclisiran as Add-On Lipid-Lowering Therapy for Patients With Cardiovascular Disease
44. 757 The Productivity Impact of Coronary Heart Disease Prevention in Australia Over Ten Years
45. PCV47 DOES THE COST-EFFECTIVENESS OF ICOSAPENT ETHYL IN COMBINATION WITH STATIN THERAPY COMPARED TO STATIN ALONE DIFFER BETWEEN PRIMARY AND SECONDARY PREVENTION?
46. PCV62 ECONOMIC EVALUATION AND NETWORK META-ANALYSIS OF NON-STATIN THERAPY AMONG STATIN-TREATED PATIENTS IN THAILAND
47. CC1 COST-EFFECTIVENESS OF SCREENING AND TREATING CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA EARLY IN LIFE FROM A DUTCH HEALTHCARE PERSPECTIVE
48. AD2 DYNAMICS OF SWITCHING, ADHERENCE, AND PERSISTENCE OF SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS USE: AN AUSTRALIAN PERSPECTIVE
49. PIH22 ESTIMATING THE PRODUCTIVITY BURDEN OF PEDIATRIC PNEUMOCOCCAL DISEASE IN THAILAND
50. Economic implications of obesity among people with atherothrombotic disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.